P21583 (SCF_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 114.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Kit ligand Alternative name(s): Mast cell growth factor Short name=MGF Stem cell factor Short name=SCF c-Kit ligand Cleaved into the following chain:
| ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 273 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins. |
| Subunit structure | Homodimer, non-covalently linked Probable. Heterotetramer with KIT, binding two KIT molecules; thereby mediates KIT dimerization and subsequent activation by autophosphorylation. |
| Subcellular location | Isoform 1: Cell membrane; Single-pass type I membrane protein Ref.9. Isoform 2: Cell membrane; Single-pass type I membrane protein By similarity. Cytoplasm › cytoskeleton By similarity Ref.9. |
| Developmental stage | Acts in the early stages of hematopoiesis. |
| Post-translational modification | A soluble form (sKITLG) is produced by proteolytic processing of isoform 1 in the extracellular domain. Found in two differentially glycosylated forms, LMW-SCF and HMW-SCF. LMW-SCF is fully N-glycosylated at Asn-145, partially N-glycosylated at Asn-90, O-glycosylated at Ser-167, Thr-168 and Thr-180, and not glycosylated at Asn-97 or Asn-118. HMW-SCF is N-glycosylated at Asn-118, Asn-90 and Asn-145, O-glycosylated at Ser-167, Thr-168 and Thr-180, and not glycosylated at Asn-97. Ref.9 A soluble form exists as a cleavage product of the extracellular domain. |
| Polymorphism | Genetic variations in KITLG are associated with variation in skin/hair/eye pigmentation type 7 (SHEP7) [MIM:611664]. Hair, eye and skin pigmentation are among the most visible examples of human phenotypic variation, with a broad normal range that is subject to substantial geographic stratification. In the case of skin, individuals tend to have lighter pigmentation with increasing distance from the equator. By contrast, the majority of variation in human eye and hair color is found among individuals of European ancestry, with most other human populations fixed for brown eyes and black hair. |
| Involvement in disease | Defects in KITLG are the cause of familial progressive hyperpigmentation (FPH) [MIM:145250]; also called melanosis universalis hereditaria (MUH). FPH is an autosomal-dominantly inherited disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age. Ref.18 |
| Sequence similarities | Belongs to the SCF family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| KIT | P10721 | 2 | EBI-1379527,EBI-1379503 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P21583-1) Also known as: SCF248; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P21583-2) Also known as: SCF220; The sequence of this isoform differs from the canonical sequence as follows: 174-202: DSRVSVTKPFMLPPVAASSLRNDSSSSNR → G | ||||||
| Isoform 3 (identifier: P21583-3) The sequence of this isoform differs from the canonical sequence as follows: 1-35: Missing. 36-43: NVKDVTKL → MPSCLAAQ | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Ref.9 | ||||||||||||||||||||||||
| Chain | 26 – 273 | 248 | Kit ligand | PRO_0000031913 | |||||||||||||||||||||||
| Chain | 26 – 190 | 165 | Soluble KIT ligand | PRO_0000403391 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Topological domain | 26 – 214 | 189 | Extracellular Potential | ||||||||||||||||||||||||
| Transmembrane | 215 – 237 | 23 | Helical; Potential | ||||||||||||||||||||||||
| Topological domain | 238 – 273 | 36 | Cytoplasmic Potential | ||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||
| Site | 97 | 1 | Not glycosylated | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Glycosylation | 90 | 1 | N-linked (GlcNAc...); partial Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 118 | 1 | N-linked (GlcNAc...); partial Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 145 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 167 | 1 | O-linked (GalNAc...) Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 168 | 1 | O-linked (GalNAc...) Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 180 | 1 | O-linked (GalNAc...) Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 195 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Disulfide bond | 29 ↔ 114 | Ref.9 Ref.15 Ref.16 Ref.17 | |||||||||||||||||||||||||
| Disulfide bond | 68 ↔ 163 | Ref.9 Ref.15 Ref.16 Ref.17 | |||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 1 – 35 | 35 | Missing in isoform 3. | VSP_032762 | |||||||||||||||||||||||
| Alternative sequence | 36 – 43 | 8 | NVKDVTKL → MPSCLAAQ in isoform 3. | VSP_032763 | |||||||||||||||||||||||
| Alternative sequence | 174 – 202 | 29 | DSRVS…SSSNR → G in isoform 2. | VSP_006022 | |||||||||||||||||||||||
| Natural variant | 36 | 1 | N → S in FPH; gain-of-function mutation; sKITLG reveales that the mutant Ser-36 sKITLG increases the content of the melanin by 109% compared with the wild-type sKITLG; tyrosinase activity is significantly increased by the mutant sKITLG compared to wild-type control. Ref.18 | VAR_063237 | |||||||||||||||||||||||
| Natural variant | 54 | 1 | T → A. Corresponds to variant rs3741457 [ dbSNP | Ensembl ]. | VAR_042652 | |||||||||||||||||||||||
| Natural variant | 210 | 1 | D → Y. Corresponds to variant rs41283112 [ dbSNP | Ensembl ]. | VAR_063238 | |||||||||||||||||||||||
| Natural variant | 232 | 1 | F → Y. Corresponds to variant rs12721563 [ dbSNP | Ensembl ]. | VAR_042653 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||
| Sequence conflict | 55 | 1 | L → S in AAD22048. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 55 | 1 | L → S in AAK92486. Ref.4 | ||||||||||||||||||||||||
| Sequence conflict | 128 | 1 | K → R in AAD22048. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 128 | 1 | K → R in AAK92486. Ref.4 | ||||||||||||||||||||||||
| Sequence conflict | 134 | 1 | L → F in AAD22048. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 134 | 1 | L → F in AAK92486. Ref.4 | ||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Helix | 37 – 45 | 9 | |||||||||||||||||||||||||
| Beta strand | 53 – 57 | 5 | |||||||||||||||||||||||||
| Turn | 59 – 63 | 5 | |||||||||||||||||||||||||
| Helix | 66 – 68 | 3 | |||||||||||||||||||||||||
| Helix | 70 – 85 | 16 | |||||||||||||||||||||||||
| Helix | 97 – 117 | 21 | |||||||||||||||||||||||||
| Beta strand | 120 – 122 | 3 | |||||||||||||||||||||||||
| Beta strand | 131 – 135 | 5 | |||||||||||||||||||||||||
| Helix | 137 – 152 | 16 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Primary structure and functional expression of rat and human stem cell factor DNAs." Martin F.H., Suggs S.V., Langley K.E., Lu H.S., Ting J., Okino K.H., Morris C.F., McNiece I.K., Jacobsen F.W., Mendiaz E.A., Birkett N.C., Smith K.A., Johnson M.J., Parker V.P., Flores J.C., Patel A.C., Fisher E.F., Erjavec H.O. Zsebo K.M.Cell 63:203-211(1990) [PubMed: 2208279] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24." Anderson D.M., Williams D.E., Tushinski R., Gimpel S., Eisenman J., Cannizzaro L.A., Aronson M., Croce C.M., Huebner K., Cosman D. Cell Growth Differ. 2:373-378(1991) [PubMed: 1724381] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [3] | "Parathyroid hormone-regulated production of stem cell factor in human osteoblasts and osteoblast-like cells." Blair H.C., Julian B.A., Cao X., Jordan S.E., Dong S.S. Biochem. Biophys. Res. Commun. 255:778-784(1999) [PubMed: 10049787] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [4] | Han C., Peng X., Yuan J., Qiang B. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Tongue and Trachea. |
| [6] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Amygdala. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Brain and Colon. |
| [9] | "Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells." Lu H.S., Clogston C.L., Wypych J., Parker V.P., Lee T.D., Swiderek K., Baltera R.F. Jr., Patel A.C., Chang D.C., Brankow D.W., Liu X.-D., Ogden S.G., Karkare S.B., Hu S.S., Zsebo K.M., Langley K.E. Arch. Biochem. Biophys. 298:150-158(1992) [PubMed: 1381905] [Abstract] Cited for: PROTEIN SEQUENCE OF 26-40; 64-79; 87-102; 110-149 AND 154-190 (ISOFORM 1), DISULFIDE BONDS, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, GLYCOSYLATION AT ASN-90; ASN-118; ASN-145; SER-167; THR-168 AND THR-180. |
| [10] | "Expression of two types of kit ligand mRNAs in human tumor cells." Toyota M., Hinoda Y., Itoh F., Tsujisaki M., Imai K., Yachi A. Int. J. Hematol. 55:301-304(1992) [PubMed: 1379846] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 167-248 (ISOFORM 2). |
| [11] | "Stem cell factor/c-kit system in spermatogenesis." Mauduit C., Hamamah S., Benahmed M. Hum. Reprod. Update 5:535-545(1999) [PubMed: 10582791] [Abstract] Cited for: REVIEW. |
| [12] | "Signal transduction via the stem cell factor receptor/c-Kit." Ronnstrand L. Cell. Mol. Life Sci. 61:2535-2548(2004) [PubMed: 15526160] [Abstract] Cited for: REVIEW. |
| [13] | "Normal and oncogenic forms of the receptor tyrosine kinase kit." Lennartsson J., Jelacic T., Linnekin D., Shivakrupa R. Stem Cells 23:16-43(2005) [PubMed: 15625120] [Abstract] Cited for: REVIEW. |
| [14] | "Genetic determinants of hair, eye and skin pigmentation in Europeans." Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Magnusson K.P., Manolescu A., Karason A., Palsson A., Thorleifsson G., Jakobsdottir M., Steinberg S., Palsson S., Jonasson F., Sigurgeirsson B., Thorisdottir K., Ragnarsson R., Benediktsdottir K.R. Stefansson K.Nat. Genet. 39:1443-1452(2007) [PubMed: 17952075] [Abstract] Cited for: INVOLVEMENT IN SHEP7. |
| [15] | "Structure of the active core of human stem cell factor and analysis of binding to its receptor kit." Jiang X., Gurel O., Mendiaz E.A., Stearns G.W., Clogston C.L., Lu H.S., Osslund T.D., Syed R.S., Langley K.E., Hendrickson W.A. EMBO J. 19:3192-3203(2000) [PubMed: 10880433] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS), DISULFIDE BONDS. |
| [16] | "Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation." Zhang Z., Zhang R., Joachimiak A., Schlessinger J., Kong X.P. Proc. Natl. Acad. Sci. U.S.A. 97:7732-7737(2000) [PubMed: 10884405] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 26-166, DISULFIDE BONDS. |
| [17] | "Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor." Yuzawa S., Opatowsky Y., Zhang Z., Mandiyan V., Lax I., Schlessinger J. Cell 130:323-334(2007) [PubMed: 17662946] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 26-166 IN COMPLEX WITH KIT, DISULFIDE BONDS. |
| [18] | "Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation." Wang Z.-Q., Si L., Tang Q., Lin D., Fu Z., Zhang J., Cui B., Zhu Y., Kong X., Deng M., Xia Y., Xu H., Le W., Hu L., Kong X. Am. J. Hum. Genet. 84:672-677(2009) [PubMed: 19375057] [Abstract] Cited for: VARIANT FPH SER-36, CHARACTERIZATION OF VARIANT FPH SER-36. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M59964 mRNA. Translation: AAA85450.1. AF119835 mRNA. Translation: AAD22048.1. AF400436 mRNA. Translation: AAK92485.1. AF400437 mRNA. Translation: AAK92486.1. AK290319 mRNA. Translation: BAF83008.1. AK293002 mRNA. Translation: BAF85691.1. CR749222 mRNA. Translation: CAH18078.1. CH471054 Genomic DNA. Translation: EAW97417.1. BC069733 mRNA. Translation: AAH69733.1. BC069783 mRNA. Translation: AAH69783.1. BC069797 mRNA. Translation: AAH69797.1. BC074725 mRNA. Translation: AAH74725.1. BC126166 mRNA. Translation: AAI26167.1. BC143899 mRNA. Translation: AAI43900.1. S42571 mRNA. Translation: AAB22846.2. | ||||||||||||||||||||||||
| IPI | IPI00009450. IPI00220142. IPI00479376. | ||||||||||||||||||||||||
| PIR | A35974. B61190. S29052. | ||||||||||||||||||||||||
| RefSeq | NP_000890.1. NM_000899.4. NP_003985.2. NM_003994.5. | ||||||||||||||||||||||||
| UniGene | Hs.1048. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P21583. | ||||||||||||||||||||||||
| SMR | P21583. Positions 27-166. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | P21583. 3 interactions. | ||||||||||||||||||||||||
| STRING | P21583. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P21583. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 134289. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | P21583. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000228280; ENSP00000228280; ENSG00000049130. ENST00000347404; ENSP00000054216; ENSG00000049130. | ||||||||||||||||||||||||
| GeneID | 4254. | ||||||||||||||||||||||||
| KEGG | hsa:4254. | ||||||||||||||||||||||||
| UCSC | uc001tav.1. human. uc001taw.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 4254. | ||||||||||||||||||||||||
| GeneCards | GC12M088823. | ||||||||||||||||||||||||
| H-InvDB | HIX0026342. | ||||||||||||||||||||||||
| HGNC | HGNC:6343. KITLG. | ||||||||||||||||||||||||
| HPA | CAB004569. | ||||||||||||||||||||||||
| MIM | 145250. phenotype. 184745. gene. 611664. phenotype. | ||||||||||||||||||||||||
| neXtProt | NX_P21583. | ||||||||||||||||||||||||
| Orphanet | 79146. Familial progressive hyperpigmentation. | ||||||||||||||||||||||||
| PharmGKB | PA30129. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | prNOG19660. | ||||||||||||||||||||||||
| GeneTree | ENSGT00390000018272. | ||||||||||||||||||||||||
| HOVERGEN | HBG036146. | ||||||||||||||||||||||||
| OrthoDB | EOG41G34W. | ||||||||||||||||||||||||
| PhylomeDB | P21583. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | kitpathway. Signaling events mediated by Stem cell factor receptor (c-Kit). | ||||||||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P21583. | ||||||||||||||||||||||||
| Bgee | P21583. | ||||||||||||||||||||||||
| CleanEx | HS_KITLG. | ||||||||||||||||||||||||
| Genevestigator | P21583. | ||||||||||||||||||||||||
| GermOnline | ENSG00000049130. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR009079. 4_helix_cytokine-like_core. IPR012351. 4_helix_cytokine_core. IPR003452. SCF. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:1.20.1250.10. 4_helix_cytokine_core. 1 hit. | ||||||||||||||||||||||||
| KO | K05461. | ||||||||||||||||||||||||
| PANTHER | PTHR11574. SCF. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF02404. SCF. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PIRSF | PIRSF015599. SCF. 1 hit. | ||||||||||||||||||||||||
| SUPFAM | SSF47266. 4_helix_cytokine. 1 hit. | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| NextBio | 16773. | ||||||||||||||||||||||||
| PMAP-CutDB | P21583. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | SCF_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P21583 Secondary accession number(s): A0AV09 Q9UQK7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with